Medical & Surgical Urology
Open Access
ISSN: 2168-9857
ISSN: 2168-9857
Marc R Matrana
Precision Cancer Therapies (Phase I ) Program, Ochsner Cancer Institute,
Tanzania
Editorial
FDA Approves an Adjuvant Targeted Therapy for Post-Surgery RCC Patients, but Questions and Clinical Challenges Remain
Author(s): Marc R MatranaMarc R Matrana
DOI:
10.4172/2168-9857.1000e121